We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$22.4B
AUM Growth
+$745M
Cap. Flow
+$687M
Cap. Flow %
3.07%
Top 10 Hldgs %
31.51%
Holding
1,352
New
72
Increased
666
Reduced
342
Closed
71

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$191M
2
MSFT icon
Microsoft
MSFT
+$116M
3
NVDA icon
NVIDIA
NVDA
+$115M
4
AAPL icon
Apple
AAPL
+$108M
5
WY icon
Weyerhaeuser
WY
+$83.8M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$118M
2
DLR icon
Digital Realty Trust
DLR
+$106M
3
CCI icon
Crown Castle
CCI
+$104M
4
SPG icon
Simon Property Group
SPG
+$93M
5
KIM icon
Kimco Realty
KIM
+$64.5M

Sector Composition

Rank Sector Weight
1 Real Estate 37.54%
2 Technology 23.33%
3 Communication Services 8.01%
4 Consumer Discretionary 6.37%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETNB
1176
DELISTED
89bio
ETNB
$3K ﹤0.01%
344
– –
GMAB icon
1177
Genmab
GMAB
$17.8B
$3K ﹤0.01%
159
– –
GRFS
1178
Grifois
GRFS
$5.44B
$3K ﹤0.01%
398
– –
IRWD icon
1179
Ironwood Pharmaceuticals
IRWD
$626M
$3K ﹤0.01%
573
-66,997
-99% -$272K
KNSA icon
1180
Kiniksa Pharmaceuticals
KNSA
$6.11B
$3K ﹤0.01%
139
– –
KURA icon
1181
Kura Oncology
KURA
$826M
$3K ﹤0.01%
297
– –
MRVI icon
1182
Maravai LifeSciences
MRVI
$1.01B
$3K ﹤0.01%
490
– –
PCRX icon
1183
Pacira BioSciences
PCRX
$1.05B
$3K ﹤0.01%
169
– –
PLRX icon
1184
Pliant Therapeutics
PLRX
$66.3M
$3K ﹤0.01%
196
– –
PRTA icon
1185
Prothena Corp
PRTA
$448M
$3K ﹤0.01%
195
– –
QURE icon
1186
uniQure
QURE
$2.52B
$3K ﹤0.01%
158
– –
XLP icon
1187
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$3K ﹤0.01%
32
– –
XLV icon
1188
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$3K ﹤0.01%
21
-10
-32% -$1.46K
AVBP icon
1189
ArriVent BioPharma
AVBP
$1.4B
$3K ﹤0.01%
+111
New +$3.19K
LENZ
1190
LENZ Therapeutics
LENZ
$184M
$3K ﹤0.01%
+91
New +$2.77K
ALT icon
1191
Altimmune
ALT
$581M
$2K ﹤0.01%
+235
New +$1.79K
ANNX icon
1192
Annexon
ANNX
$814M
$2K ﹤0.01%
+352
New +$2.17K
ARCT icon
1193
Arcturus Therapeutics
ARCT
$163M
$2K ﹤0.01%
90
– –
ATXS
1194
DELISTED
Astria Therapeutics
ATXS
$2K ﹤0.01%
+186
New +$1.98K
CRGX
1195
DELISTED
CARGO Therapeutics
CRGX
$2K ﹤0.01%
+152
New +$2.76K
CRMD icon
1196
CorMedix
CRMD
$577M
$2K ﹤0.01%
+200
New +$2K
CSTL icon
1197
Castle Biosciences
CSTL
$725M
$2K ﹤0.01%
86
– –
CVAC
1198
DELISTED
CureVac
CVAC
$2K ﹤0.01%
697
– –
HUMA icon
1199
Humacyte
HUMA
$170M
$2K ﹤0.01%
301
– –
IEUR icon
1200
iShares Core MSCI Europe ETF
IEUR
$8.82B
$2K ﹤0.01%
+29
New +$1.65K
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2024 Portfolio in Review

As of Q4 2024, Daiwa Securities Group held 1,352 positions worth $22.4B, up 3.4% from $21.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group deployed $687M of net new capital in Q4 2024, opening 72 new positions and adding to 666 existing holdings. Its largest new stake was Curbline Properties: 2,033,334 shares worth $47.2M.

By sector, the portfolio is most concentrated in Real Estate at 38% of assets, down from 42% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $118M trimmed.

  • Daiwa Securities Group's largest Q4 2024 buy was Curbline Properties: 2,033,334 shares worth $47.2M.
  • Daiwa Securities Group added most to American Tower in Q4 2024, an estimated $191M increase.
  • Daiwa Securities Group's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $118M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2024, selling an estimated $10.3M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $22.4B portfolio in Q4 2024.
  • Daiwa Securities Group opened 72 new positions and closed 71 in Q4 2024.
  • Daiwa Securities Group's portfolio value rose 3.4% quarter-over-quarter to $22.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.